文献速递肝胆胰外科

开腹与微创胰腺肿瘤剜除术的系统综述

Open and minimally invasive pancreatic neoplasms enucleation: a systematic review.
PubMed 文献 · Surg Endosc · 2019-07-30

结果显示微创pEN显著降低总体POPF率(28.7% vs. 45.9%,p<0.001)和临床显著B-C级POPF(p<0.027),总体术后并发症率也显著降低(27.6% vs. 55.2%,p<0.001)。

要点

  • 微创pEN的总体POPF率显著低于开腹(28.7% vs. 45.9%,p<0.001)。
  • 微创pEN的总体术后并发症率显著低于开腹(27.6% vs. 55.2%,p<0.001)。
  • pEN治疗小良性或低级别胰腺肿瘤安全可行,死亡率0.69%。

核心结论

  • pEN治疗小良性或低级别胰腺肿瘤安全可行,并发症率可接受且死亡率低。
  • 微创pEN在POPF发生率和短期术后结局方面优于开腹,但需随机临床试验证实。

研究设计与样本

  • 系统综述,检索1999年1月至2018年9月文献,纳入至少5例开腹或微创pEN的研究。

主要发现

  • 总体术后并发症率为46.1%,严重并发症(Clavien-Dindo≥3)占11.9%,死亡率为0.69%。
  • 微创pEN总体POPF率为28.7%,开腹为45.9%,差异有统计学意义(p<0.001)。
  • 微创pEN临床显著B-C级POPF显著低于开腹(p<0.027)。
  • 微创pEN总体术后并发症率为27.6%,开腹为55.2%,差异有统计学意义(p<0.001)。

关键数值与推荐

  • 术后并发症采用Clavien-Dindo分类定义,POPF采用ISGPF定义。

临床怎么用

  • 对于小良性或低级别胰腺肿瘤,pEN是安全可行的保留实质术式。
  • 微创pEN可降低POPF和总体并发症风险,可作为优先考虑的手术方式。

局限性

  • 数据需随机临床试验进一步证实。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Pancreatic enucleation (pEN) as parenchyma-sparing procedure for small pancreatic neoplasms is quickly becoming the most common surgical option in such setting. Nowadays, pEN is frequently carried out through a minimally invasive approach either laparoscopic or robotic. Its impact on overall perioperative complications and pancreatic fistula (POPF) is still under evaluation. The scope of our systematic review is to assess pEN's perioperative outcomes and to evaluate the effect of the minimally invasive techniques over POPF and other surgical complications. METHODS: We performed a systematic literature search (time-frame January 1999-September 2018), considering exclusively those studies which included at least 5 cases of either open or minimally invasive pEN. Data regarding postoperative outcome and POPF were extracted and analyzed. We defined postoperative morbidities by the Clavien-Dindo classification while POPF according to the International Study Group of Pancreatic Fistula (ISGPF) definition. RESULTS: Sixty-three studies met the criteria selected, accounting for a study population of 2485 patients. 27.7% had a minimally invasive pEN. The overall postoperative morbidity rate was 46.1% with 11.9% rated as severe (Clavien-Dindo ≥ 3). Mortality rate was 0.69%. The minimally invasive approach to pEN led to a statistically significant reduction of both the overall POPF rate (28.7% vs. 45.9%, p < 0.001), and clinically significant B-C POPF (p < 0.027). The postoperative overall morbidity rate was clearly in favor of the minimally invasive approach (27.6% vs. 55.2%, p < 0.001). CONCLUSIONS: Our review confirms that pEN is a safe and feasible technique for the treatment of small benign or low-grade pancreatic neoplasms and it can be implemented with an acceptable morbidity rate along with low mortality. The minimally invasive approach is gaining widespread acceptance due to its supposed non-inferiority compared with the traditional open approach. In our review, it showed to be even better in terms of POPF incidence rate and short-term postoperative outcome. Still, such data need to be corroborated by randomized clinical trials.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Dalla Valle R, Cremaschi E, Lamecchi L, et al. Open and minimally invasive pancreatic neoplasms enucleation: a systematic review. Surg Endosc. 2019. PMID: 31363894. doi:10.1007/s00464-019-06967-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。